Summary
Many patients undergoing surgery for gastric carcinoma will develop peritoneal metastases. A method to identify those patients at risk of peritoneal recurrence would help in the selection of patients for adjuvant therapy. Peritoneal cytology has received little attention in the West, but may prove a useful additional means of evaluating patients with gastric cancer. The aims of this study were to evaluate sampling techniques for peritoneal cytology in patients with gastric cancer, to assess the prognostic significance of free peritoneal malignant cells and to discover the effect of the operative procedure on dissemination of malignant cells. The study is based on 85 consecutive patients undergoing surgical treatment of gastric cancer and followed up for 2 years or until death. Peritoneal cytology samples were collected at laparoscopy, and at operation prior to resection by intraperitoneal lavage and serosal brushings. After resection, samples were taken by peritoneal lavage, imprint cytology of the resected specimen and post-operatively by peritoneal irrigation via a percutaneous catheter. Malignant cells were diagnosed by two independent microscopists. Preoperative peritoneal lavage yielded malignant cells in 16 out of 85 cases (19%). The yield of free malignant cells was increased by using serosal brushings (by four cases) and imprint cytology (by two cases); all of the cases had evidence of serosal penetration. One serosa-negative case exhibited positive cytology in the post-resection peritoneal specimen in which the preresection cytology specimen was negative. Survival was worse in the cytology-positive group (χ2 = 25.1; P < 0.0001). Among serosa-positive patients, survival was significantly reduced if cytology was positive, if cases yielded by brushings and imprint cytology were included (log-rank test = 8.44; 1 df, P = 0.004). In conclusion, free peritoneal malignant cells can be identified in patients with gastric cancer who have a poor prognosis; the yield can be increased with brushings and imprint cytology in addition to conventional peritoneal lavage. Evaluation of peritoneal cytology by these methods may have a role in the selection of patients with the poorest prognosis who may benefit most from adjuvant therapy.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Allum, W. H., Powell, D. J., McConkey, C. C. & Fielding, J. W. L. (1989a). Gastric cancer: a 25-year review. Br J Surg 76: 535–540.
Allum, W. H., Hallissey, M. T., Ward, L. C. & Hockey, M. S. (1989b). A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. Br J Cancer 60: 739–744.
Bonenkamp, J. J., Songun, I., Hermans, J. & van de Velde, C. J. H. (1996). Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 83: 672–674.
Boku, T., Nakane, Y., Minoura, T., Takada, H., Yamamura, M., Hioki, K. & Yamamoto, M. (1990). Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 77: 436–439.
Cunliffe, W. J. & Sugarbaker, P. H. (1989). Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 76: 1082–1090.
Gunderson, L. L. & Sosin, H. (1982). Adenocarcinoma of the stomach: areas of failure in a reoperation series (second or symptomatic look) clinicopathological correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8: 1–11.
Hagiwara, A., Takahashi, T., Kojima, O., Sawai, K., Yamaguchi, T., Yamane, T., Taniguchi, H., Kitamura, K., Noguchi, A., Seiki, K. & Sakakura, C. (1992). Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 339: 629–631.
Hallissey, M., Dunn, J., Ward, L. & Allum, W. (1994). The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 343: 1309–1312.
Iitsuka, Y., Kaneshima, S., Tanida, O., Takeuchi, T. & Koga, S. (1979). Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 44: 1476–1480.
Kaibara, N., Iitsuka, Y., Kimura, A., Kobayashi, Y., Hirooka, Y., Nishidoi, H. & Koga, S. (1987). Relationship between area of serosal invasion and prognosis in patients with gastric carcinoma. Cancer 60: 136–139.
Kennedy, B. J. (1987). The unified international gastric cancer staging classification system. Scand J Gastroenterol 22: (suppl. 133) 11–13.
Koss, L. G. (1992). Diagnostic cytology and its histopathologic basis, 4th edn, pp. 126–137, JB Lippincott: Philadelphia
Murphy, P. D., Wadhera, V., Griffith, S. M., Burgess, P., Farrell, D., Taylor, I., Hair, T., Clague, M. B. & Griffith, C. D. M. (1993). Free peritoneal cell identification in patients with gastric and colorectal cancer. J R Coll Surg Edinburgh 38: 28–32.
Nakajima, T., Harashima, S., Hirata, M. & Kajitani, T. (1978). Prognostic and therapeutic value of peritoneal cytology in gastric cancer. Acta Cytol 22: 225–229.
Papachristou, D. N. & Fortner, J. G. (1981). Local recurrence of gastric adenocarcinomas after gastrectomy. J Surg Oncol 18: 47–53.
Soosay, G. N., Griffiths, M., Papadaki, L., Happerfield, L. & Bobrow, L. (1991). The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation. J Pathol 163: 299–305.
Sue-Ling, H., Johnston, D., Martin, I. G., Dixon, M. F., Lansdown, M. R. J., McMahon, M. J. & Axon, A. T. R. (1993). Gastric cancer: a curable disease in Britain. Br Med J 307: 591–596.
Sugarbaker, P. H., Cunliffe, W., Belliveau, J. F., De Bruijn, E. A., Graves, T., Mullins, R., Schlag, P. & Gianola, F. (1988). Rationale for perioperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Reg Cancer Treat 1: 66–79.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Hayes, N., Wayman, J., Wadehra, V. et al. Peritoneal cytology in the surgical evaluation of gastric carcinoma. Br J Cancer 79, 520–524 (1999). https://doi.org/10.1038/sj.bjc.6690081
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690081
Keywords
This article is cited by
-
Gastric Carcinoma—a New Biomarker Peritoneal Fluid Lavage Cytology
Indian Journal of Surgery (2022)
-
Comparison of prognostic impact between positive intraoperative peritoneal and lavage cytologies in colorectal cancer
International Journal of Clinical Oncology (2021)
-
Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens—A review and evidence-based guide
Indian Journal of Surgical Oncology (2019)
-
The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
Journal of Experimental & Clinical Cancer Research (2018)
-
Incidence and prognostic significance of positive peritoneal lavage in colorectal cancer
Surgery Today (2015)